Hematology/Oncology

It was well established that inflammation has a complex association with carcinogenesis, tumor...

In a side-by-side comparison study in patients with relapsed/refractory (R/R) chronic lymphocytic...

In order to enable early treatment and prevent the emergence of end-organ damage during the...

Patients with hematological malignancies (HM) continue to face COVID-19 as a pertinent problem. In...

KRAS has proved impossible to target despite being a frequent variation (~20% of non-small-cell...

The third most prevalent cause of cardiovascular death is deep vein thrombosis (DVT). According to...

For a study, researchers created a deep-scale proteome and phosphoproteome database using 6...

The lymphoid tumor known as adult T-cell leukemia (ATL) is brought on by human T-cell leukemia...

Vacuoles, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory somatic (VEXAS) syndrome, an...

The reversible P2Y12 inhibitor ticagrelor was compared to a placebo in phase 3 HESTIA3 research to...

Glucocorticoid-induced TNF receptor-related protein (GITR) is the target of the monoclonal...

Safety and efficacy of the oral bromodomain and extraterminal inhibitor GS-5829, both alone and in...

In PNOC003, children and young people with a recent diagnosis of diffuse intrinsic pontine glioma...

Although toxicity and resistance have restricted ibrutinib’s application, the drug has...

The topic of cancer immunology has seen a surge of attention in recent years because of the...

Developments in the understanding of T-cell biology and immune-tumor cell interactions have...